| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
13,671 |
11,636 |
$494K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,910 |
2,812 |
$102K |
| 99233 |
Prolong inpt eval add15 m |
1,075 |
550 |
$37K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
2,888 |
1,727 |
$29K |
| 90961 |
|
741 |
648 |
$21K |
| 90937 |
|
807 |
495 |
$15K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
184 |
151 |
$5K |
| 99490 |
Ccm add 20min |
129 |
123 |
$2K |
| 99223 |
Prolong inpt eval add15 m |
28 |
24 |
$649.02 |
| 99152 |
|
40 |
25 |
$322.70 |
| 99222 |
Initial hospital care, per day, moderate complexity |
13 |
12 |
$319.43 |
| 99497 |
|
28 |
27 |
$214.50 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
27 |
25 |
$71.89 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
21 |
13 |
$33.70 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
22 |
13 |
$0.50 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
22 |
13 |
$0.02 |